Prof. Mok Shu Kam Tony

  • Qualification:
    • BMSc, MD, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO
  • Specialty:
    • Lung Cancer
    • Hepatocellular Carcinoma
  • Current Position at CU:
    • Li Shu Fan Professor of Clinical Oncology, Department of Clinical Oncology
    • Chairman, Department of Clinical Oncology
  • Areas of research:
    • Molecular targeted therapy on epidermal growth factor receptor (EGFR)
    • Development of biomarker for personalized medicine in lung cancer
    • Mechanism for and management of resistance to EGFR tyrosine kinase inhibitor
    • Development of novel targeted therapy (ELM-4 ALK, c-MET, IGF-1R)
    • Tumor vaccine against lung cancer (MAGE A3, MUC-1)
    • Immunotherapy
    • Plasma-based cfDNA for molecular diagnosis
  • Additional Roles:
    • Fellow of ASCO (FASCO)
    • Member of ASCO Board of Director (June 2018 - May 2022)
    • Past President, International Association for the Study of Lung Cancer (IASLC)
    • Member of The Hong Kong Academy of Science

Hyperlink to personal webpage in host dept and other institutes